Evidence map›Paper›PMID 22940101›Full record

ArticleJournal of microbiological methods2012

Adaptation of the neutral bacterial comet assay to assess antimicrobial-mediated DNA double-strand breaks in Escherichia coli.

Dipesh Solanky, Shelley E Haydel

Open access · greenAbstract read
In one paragraph

Article in Journal of microbiological methods, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Effect of Pefloxacin onAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Open life sciences · 2023
    Article
  6. Article
  7. Article
  8. Frontiers in microbiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dipesh SolankySchool of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
Shelley E Haydel
Arizona State University · US

Funding

Antibacterial activities of natural minerals and alternative treatment for infectR01AT004690 · NCCIH · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HAYDEL, SHELLEY E · 2009 to 2013
$1.6M
NCCIH NIH HHS AT004690NCCIH NIH HHS R01 AT004690
6 · The paper itself

Abstract

This study aimed to determine the mechanism of action of a natural antibacterial clay mineral mixture, designated as CB, by investigating the induction of DNA double-strand breaks (DSBs) in Escherichia coli. To quantify DNA damage upon exposure to soluble antimicrobial compounds, we modified a bacterial neutral comet assay, which associates the general length of an electrophoresed chromosome, or comet, with the degree of DSB-associated DNA damage. To appropriately account for antimicrobial-mediated strand fragmentation, suitable control reactions consisting of exposures to water, ethanol, kanamycin, and bleomycin were developed and optimized for the assay. Bacterial exposure to the CB clay resulted in significantly longer comet lengths, compared to water and kanamycin exposures, suggesting that the induction of DNA DSBs contributes to the killing activity of this antibacterial clay mineral mixture. The comet assay protocol described herein provides a general technique for evaluating soluble antimicrobial-derived DNA damage and for comparing DNA fragmentation between experimental and control assays.

Indexed as

Aluminum SilicatesAnti-Bacterial AgentsClayComet AssayDNA, BacterialDNA Breaks, Double-StrandedEscherichia coliAluminum SilicatesAnti-Bacterial AgentsClayDNA, Bacterial

Identifiers

PMID22940101
PMCPMC3486642
OpenAlexW2022758415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.